Iodotope Interactions
There are 165 drugs known to interact with Iodotope (sodium iodide-i-131), along with 2 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 1 is major, and 164 are moderate.
- View all 165 medications that may interact with Iodotope
- View Iodotope alcohol/food interactions (2)
- View Iodotope disease interactions (2)
Most frequently checked interactions
View interaction reports for Iodotope (sodium iodide-i-131) and the medicines listed below.
- AccessPak for HIV PEP Expanded with Kaletra (emtricitabine / lopinavir / ritonavir / tenofovir)
- Actemra (tocilizumab)
- Adcetris (brentuximab)
- Adriamycin PFS (doxorubicin)
- Adriamycin RDF (doxorubicin)
- Aptivus (tipranavir)
- Atgam (lymphocyte immune globulin, anti-thy (equine))
- Avastin (bevacizumab)
- Banzel (rufinamide)
- Benadryl (diphenhydramine)
- BeneFix (coagulation factor ix)
- Benlysta (belimumab)
- Besponsa (inotuzumab ozogamicin)
- Bexxar (iodine i 131 tositumomab)
- bezlotoxumab
- bleomycin
- Blincyto (blinatumomab)
- Celebrex (celecoxib)
- CellCept (mycophenolate mofetil)
- Complera (emtricitabine / rilpivirine / tenofovir)
- Enbrel (etanercept)
- Imbruvica (ibrutinib)
- Kalydeco (ivacaftor)
- NovoSeven RT (coagulation factor viia)
- Procysbi (cysteamine)
- Pulmozyme (dornase alfa)
- ReoPro (abciximab)
- Stivarga (regorafenib)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir)
- strontium-89 chloride
Iodotope alcohol/food interactions
There are 2 alcohol/food interactions with Iodotope (sodium iodide-i-131).
Iodotope disease interactions
There are 2 disease interactions with Iodotope (sodium iodide-i-131) which include:
Report options
QR code containing a link to this page
More about Iodotope (sodium iodide-i-131)
- Iodotope consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: antithyroid agents
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
